These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21553703)

  • 1. Alternative drug therapies for dementia.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2011 May; 49(5):17-20. PubMed ID: 21553703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
    Grossberg GT; Edwards KR; Zhao Q
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Alzheimer disease.
    Winslow BT; Onysko MK; Stob CM; Hazlewood KA
    Am Fam Physician; 2011 Jun; 83(12):1403-12. PubMed ID: 21671540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
    Schölzel-Dorenbos CJ;
    Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cholesterol inhibitor and memantine in symptomatic dementia therapy].
    Rodda J; Carter J
    Praxis (Bern 1994); 2013 Feb; 102(5):293-300; discussion 298-9. PubMed ID: 23446240
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dementing disorders. What benefits do the new anti-dementia drugs have?].
    Ihl R
    MMW Fortschr Med; 2002 May; Suppl 2():24-6, 28-9. PubMed ID: 12070846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
    Prasher VP
    Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do we treat people with dementia in Croatia.
    Mimica N; Presecki P
    Psychiatr Danub; 2010 Jun; 22(2):363-6. PubMed ID: 20562784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the horizon: pathways for drug development in Alzheimer's disease.
    Hake AM; Farlow MR
    Clin Geriatr Med; 2004 Feb; 20(1):141-52. PubMed ID: 15062492
    [No Abstract]   [Full Text] [Related]  

  • 11. [Alzheimer's disease: from brain lesions to new drugs].
    Forette F; Hauw JJ
    Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy for Alzheimer's disease].
    Shoji M
    Brain Nerve; 2010 Jul; 62(7):777-85. PubMed ID: 20675882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs to treat Alzheimer's disease.
    J Psychosoc Nurs Ment Health Serv; 2013 Apr; 51(4):11-2. PubMed ID: 23565878
    [No Abstract]   [Full Text] [Related]  

  • 14. Current pharmacotherapies for Alzheimer's disease.
    Knopman DS
    Geriatrics; 1998 Sep; 53 Suppl 1():S31-4. PubMed ID: 9745634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors.
    Jones RW
    Int J Geriatr Psychiatry; 2010 Jun; 25(6):547-53. PubMed ID: 20049770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modern therapy for dementia].
    Padberg F; Möller HJ; Bottlender R; Hampel H
    MMW Fortschr Med; 2005 May; 147 Spec No 2():71-4, 76-7. PubMed ID: 15968877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients?
    Sevilla C; Jiménez Caballero PE; Alfonso V; González-Adalid M
    Dement Geriatr Cogn Disord; 2009; 28(3):196-205. PubMed ID: 19738386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).
    Olin JT; Bhatnagar V; Reyes P; Koumaras B; Meng X; Brannan S
    Int J Geriatr Psychiatry; 2010 Apr; 25(4):419-26. PubMed ID: 19670390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatments in Alzheimer's disease: risks and benefits.
    Sobow T
    Expert Rev Neurother; 2010 May; 10(5):693-702. PubMed ID: 20420490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.